sc13g
 

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No.    )*

SPECTRUM PHARMACEUTICALS, INC.
(Name of Issuer)
Common Stock, $.001 par value per share
(Title of Class of Securities)
84763A 10 8
(CUSIP Number)
December 31, 2005
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

Page 1 of 5 pages

 

                     
CUSIP No.
  
84763A 10 8 

 

           
1   NAMES OF REPORTING PERSONS:
Rajesh C. Shrotriya
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
  (a)   o
  (b)   o
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  U.S.A.
       
  5   SOLE VOTING POWER:
     
NUMBER OF   1,372,676
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   1,372,676
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  1,372,676
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  5.53%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  IN

Page 2 of 5 pages

 

Item 1.
  (a)   Name of Issuer: Spectrum Pharmaceuticals, Inc.
 
  (b)   Address of Issuer’s Principal Executive Offices:
 
      157 Technology Drive
Irvine, California 92618
Item 2.
  (a)   Name of Person Filing: Rajesh C. Shrotriya
 
  (b)   Address of Principal Business Office:
 
      157 Technology Drive
Irvine, CA 92628
 
  (c)   Citizenship: U.S.A.
 
  (d)   Title of Class of Securities: Common Stock, $.001 par value per share
 
  (e)   CUSIP Number: 84763A 10 8
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
             
 
  (a)   o   Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
 
            
 
            
 
  (b)   o   Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
 
            
 
  (c)   o   Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
 
            
 
  (d)   o   Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
 
            
 
  (e)   o   An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
 
            
 
  (f)   o   An employee benefit plan or endowment fund in accordance with §13d-1(b)(1)(ii)(F).
 
            
 
  (g)   o   A parent holding company or control person in accordance with §13d-1(b)(1)(ii)(G).
 
            
 
  (h)   o   A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
 
            
 
  (i)   o   A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
 
            
 
  (j)   o   Group, in accordance with §240.13d-1(b)(1)(ii)(J).
Item 4. Ownership.
  (a)   Amount beneficially owned: 1,372,676 shares of Common Stock.
 
  (b)   Percent of class: 5.53%.
 
  (c)   Number of shares as to which the person has:
  (i)   Sole power to vote or to direct the vote: 1,372,676
 
  (ii)   Shared power to vote or to direct the vote: 0
 
  (iii)   Sole power to dispose or to direct the disposition: 1,372,676
 
  (iv)   Shared power to dispose or to direct the disposition: 0

 

 

Item 5. Ownership of Five Percent or Less of a Class.
     If this statement is being filed to report the fact that as of the date hereof the reported person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: o
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
     Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
     Not applicable.
Item 8. Identification and Classification of Members of the Group.
     Not applicable.
Item 9. Notice of Dissolution of Group.
     Not applicable.
Item 10. Certification.
     Not applicable.

 

 

SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
         
     
Date: February 14, 2006  /s/ Rajesh C. Shrotriya    
  Name:   Rajesh C. Shrotriya